Latest News US NCI Sponsors Senhwa Biosciences’ Second Program-IND Submitted for Clinical Trial Targeting MYC-Aberrant Lymphoma Aug 07 2025 Latest News Senhwa Biosciences announces first patient dosed in NCI-sponsored pilot study of Pidnarulex (CX-5461) pharmacodynamics in patients with advanced solid tumors Jul 16 2025 Latest News Senhwa Biosciences Highlights Breakthroughs in Dual First-in-Class Drug Programs at Annual Shareholders’ Meeting Today Jun 25 2025 Media Coverage Senhwa Biosciences Highlights Breakthroughs in Dual First-in-Class Drug Programs at Annual Shareholders' Meeting Today Jun 25 2025 Media Coverage Seven biotech companies keeping Taiwan dynamic in 2025 Mar 07 2025 Media Coverage Penn State College of Medicine, Beat Childhood Cancer Research Consortium and Four Diamonds launch clinical trial that aims to combat solid tumors Sep 30 2024 Publications Fibroblast growth receptor 1 is regulated by G-quadruplex in metastatic breast cancer Aug 09 2024 Publications CX-5461 Preferentially Induces Top2α-Dependent DNA Breaks at Ribosomal DNA Loci. Jul 08 2024 Publications Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options Sep 22 2023